Daejeon, South Korea

Yoon Hyeok Lee

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Intelligent Synthetic Biology Center, Korea Advanced Institute of Science and Technology. Active years: 2019-2021.


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoon Hyeok Lee: Innovator in Pharmaceutical and Synthetic Biology

Introduction

Yoon Hyeok Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of pharmaceutical compositions and synthetic biology. With a total of 2 patents, his work focuses on improving health outcomes through innovative solutions.

Latest Patents

One of his latest patents is a pharmaceutical composition for improving, preventing, or treating muscle-related diseases, which comprises ginsenoside Rh2 as an active ingredient. This invention aims to provide a composition that can prevent, alleviate, or treat muscular diseases effectively. Another notable patent is a method of preparing cinnamaldehyde using a recombinant microorganism, showcasing his expertise in synthetic biology.

Career Highlights

Yoon Hyeok Lee has worked with esteemed institutions such as the Korea Advanced Institute of Science and Technology and the Intelligent Synthetic Biology Center. His career reflects a commitment to advancing scientific knowledge and practical applications in health and biology.

Collaborations

He has collaborated with notable colleagues, including Gwan-Su Yi and Yi Li, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yoon Hyeok Lee's contributions to pharmaceutical and synthetic biology highlight his role as a key innovator in these fields. His patents and collaborations demonstrate a dedication to improving health through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…